Phosphorylated Tau 181 Serum Levels Predict Alzheimer’s Disease in the Preclinical Stage

BACKGROUND: There is an urgent need for cost-effective, easy-to-measure biomarkers to identify subjects who will develop Alzheimer’s disease (AD), especially at the pre-symptomatic stage. This stage can be determined in autosomal dominant AD (ADAD) which offers the opportunity to observe the dynamic...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Wei, Li, Fangyu, Jia, Longfei, Wang, Qi, Li, Ying, Wei, Yiping, Li, Yan, Jin, Hongmei, Jia, Jianping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Aging Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234327/
https://www.ncbi.nlm.nih.gov/pubmed/35769604
http://dx.doi.org/10.3389/fnagi.2022.900773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234327/
https://www.ncbi.nlm.nih.gov/pubmed/35769604
http://dx.doi.org/10.3389/fnagi.2022.900773

Ejemplares similares